Literature DB >> 29546747

Principles of hemodynamics for mechanical circulatory support: patho-physiological key aspects of assisted PCI.

Eloisa Basile1, Giulio Russo1, Antonio M Leone2.   

Abstract

It is essential to understand the pathophysiology of cardiogenic shock and the possible deterioration of contractile function during high-risk PCI in order to select those patients who could benefit from mechanical support thus choosing the most suitable device in every situation. Percutaneous ventricular assist devices (pVAD) provide hemodynamic support by improving cardiac output and mean arterial pressure, but their specific features result in different hemodynamic effects and degrees of myocardial ischemic protection and left ventricle unloading. These features, together with ease of use, specific contraindications and individual risk of complications, must be taken into account in the evaluation and selection of the device. The aim of this review is to illustrate the principles of left ventricular mechanic, including the pressure-volume loop analysis, in order to better understand and to quantify the different hemodynamic effects of pVAD supports and to explain the pathophysiological key aspects of assisted PCI.

Entities:  

Mesh:

Year:  2018        PMID: 29546747     DOI: 10.23736/S0026-4725.18.04658-3

Source DB:  PubMed          Journal:  Minerva Cardioangiol        ISSN: 0026-4725            Impact factor:   1.347


  2 in total

1.  Of Size and Men: A Call for Larger Trials and Meta-Analyses on Vasopressors During General Anesthesia.

Authors:  Giuseppe Biondi-Zoccai; Elena Cavarretta; Giacomo Frati; Francesco Versaci
Journal:  J Cardiothorac Vasc Anesth       Date:  2020-09-15       Impact factor: 2.628

2.  Can we have a rationalized selection of intra-aortic balloon pump, Impella, and extracorporeal membrane oxygenation in the catheterization laboratory?

Authors:  Giulio Russo; Francesco Burzotta; Cristina Aurigemma; Daniela Pedicino; Enrico Romagnoli; Carlo Trani
Journal:  Cardiol J       Date:  2020-12-21       Impact factor: 2.737

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.